Blood Banking

Pooled Plasma Derivatives Are Unlikely Mode of CJD Transmission

Published in Blood Weekly, December 18th, 1995

There is little if any justification for the actions taken in the United States in response to a blood donor who developed Creutzfeldt-Jakob disease (CJD), according to two researchers from California.

Data show no risk for the transmission of CJD from pooled plasma products, stated Eva A. Operskalski and James W. Mosley, University of Southern California, Los Angeles, California ("Pooled Plasma Derivatives and Creutzfeldt-Jakob Disease," Lancet, 1995;347:1224).

Operskalski and Mosley indicated that if CJD actually is transmitted by plasma derivatives, then enough time has passed to observe CJD in hemophiliacs, yet no such cases have been...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1995-12-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry